Global vitreous tamponades market is estimated to be valued at USD 84.7 Mn in 2024 and is expected to reach USD 108.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031. Rising prevalence of ophthalmic disorders and increasing incidence of retinal detachment across the globe can boost demand for vitreous tamponades in surgical procedures.
To learn more about this report, request sample copy
Growing elderly population who are more prone to developing retinal disorders can drive the market growth. Furthermore, ongoing research and development activities for developing advanced and long-lasting tamponades can offer new growth opportunities to market players.
Rising prevalence of retinal detachment
Rising prevalence of retinal detachment cases across the globe can drive the global vitreous tamponades market growth. Retinal detachment occurs when the retina peels away from its underlying layer of tissues called retinal pigment epithelium. It is a potentially blinding condition that needs immediate medical attention and often requires surgery. A According to the data published by U.S. National Eye Institute, about 1 in 10,000 people every year experience a retinal detachment in the U.S. The risk increases with age, high nearsightedness, eye injury, and certain health conditions like diabetes. With overall growing global population and longer life expectancy, especially in developed countries, there has been increase in number of elderly individuals who are more prone to retinal detachment. As per the data published by United Nations, the population aged 65 years or over is projected to increase from 727 million in 2020 to 1.5 billion in 2050 worldwide. This demographic shift can increase the prevalence of retinal detachment cases, thus, boosting demand for vitreous tamponades. Vitreous tamponades act as an internal bandage helping seal retinal breaks and flattening the detached retina against the retinal pigment epithelium during retina reattachment surgery.
Growing awareness regarding vitreoretinal disorders
Growing awareness about vitreoretinal disorders and their treatment options can drive the global vitreous tamponades market growth. Various vision impairment organizations and nonprofit eye care providers across the world have intensified their efforts to educate people about various retina-related conditions like retinal detachment, macular pucker/hole, and proliferative vitreoretinopathy. This has translated to more patients seeking medical attention at early stages. Furthermore, advancements in ophthalmic surgery techniques with the aid of improved tamponade agents have boosted the clinical outcomes for vitreoretinal procedures. Temporary tamponades like silicone oils and long-acting gas bubbles help surgeons achieve longer lasting retinal reattachment during complex retinal detachment repair. In 2021, according to the report published by the International Agency for the Prevention of Blindness, over 1.1 million vitrectomy surgeries were performed worldwide for various vitreoretinal disorders. A major portion of these procedures utilized some form of internal tamponade to seal retinal breaks. There will be huge demand for safer and more durable tamponades as more premium IOLs and pharmacologic vitreolysis agents become available. Surgeons would prefer agents that minimize recurrent retinal detachment risk as well as complications like elevated intraocular pressure and cataract formation.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients